Company news

Siegfried Holding AG news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Siegfried delivers profitable growth and confirms outlook

August 21, 2026

Siegfried delivers profitable growth and confirms outlook

August 21, 2026

Change in Siegfried’s management team

July 16, 2026

Change in Siegfried's management team

July 16, 2026

Siegfried strengthens manufacturing network with new large-scale drug substance facility in Minden

June 16, 2026

Change in Siegfried's Management Team

June 1, 2026

Siegfried successfully places senior bonds of CHF 200 million

May 26, 2026

Siegfried included in Dow Jones Best-in-Class Europe Index

May 7, 2026

SK Capital Partners Completes Sale of Noramco, Extractas Biosciences, and Purisys to Siegfried Holding AG

May 1, 2026

Siegfried DINAMIQS receives Swissmedic license for viral vector manufacturing

April 29, 2026

Siegfried obtains antitrust clearance for acquisition of three drug substances sites in the US and Australia

April 24, 2026

Siegfried obtains antitrust clearance for acquisition of three drug substances sites in the US and Australia

April 24, 2026

Siegfried shareholders approve all proposals at Annual General Meeting 2026

April 16, 2026

Financial Report (Siegfried 2025 AR Financial Report EN)

February 20, 2026

Siegfried delivers strong profitability and continued growth

February 20, 2026

Media release (18022024 Siegfried Media Release FYR 2024 EN)

February 19, 2026

Changes to Siegfried's Board of Directors

February 5, 2026

SK Capital Partners Announces Agreement to Sell Noramco, Extractas Biosciences, and Purisys to Siegfried Holding AG

January 27, 2026

Siegfried announces Chief Financial Officer transition

November 17, 2025

Siegfried successfully places senior bonds of CHF 300 million

September 11, 2025

Siegfried on track to deliver profitable growth

August 21, 2025

Calls

Decks

The 5 newest of 20 decks. Every deck is listed under its year.